SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Beat The Street With SI Traders
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: czechmate who wrote (119927)8/30/2013 1:14:57 PM
From: Dav!d  Read Replies (2) of 233846
 
Below is why I am really interested in PHM. People on coumadin need to go get their levels checked 2-3 times per week when starting coumadin. Thereafter, they need to get it checked once every 2 weeks. They have to drive to a coumadin clinic to get their levels checked. Very inconvenient.

The only problem with this is that there are new anti-coagulants on the market where you don't need to get your levels checked (i.e. Pradaxa). I strongly believe that coumadin is a much safer medication than pradaxa with regards to trauma since Pradaxa is not reversible whereas coumadin is.

Just my thoughts.

David.

Cardiology Market Opportunity

Over 4 million patients in the US undergo Coumadin® therapy for chronic conditions, making the patient self testing market (PST) market a potential a $6.5 billion opportunity. The market is in its infancy currently, as Medicare just recently approved payment for in home PST. It is expected to be a muilti-billion dollar market annually as it matures.

With more than 95% of this market unserved, a handful of companies are competing to enroll patients into PST programs. These companies must provide both the in home testing equipment and the continued service of monitoring patient PT/INR results and transmitting them to the physician. This creates a high barrier to entry as alignment with a device manufacturer and sufficient purchasing capital is required to provide patients with devices and ongoing service.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News